1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-05-28
No share classes in the SEC snapshot.
2,774 filed series have no class in company_tickers_mf.json, so no ticker can be reached for them.
N-PORT Item C.4.a
N-PORT Item C.4.b
as filed
135 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▲ | Country |
|---|---|---|---|---|---|---|---|
| Akero Therapeutics Inc. | — | — — | EC CORP | 28,986 NS | $18.8K | 0.001% |
| US |
| CHICAGO MERCANTILE EXCHANGE FUTURE - CASH SETTLED | — | — — | DE CORP | 67 NC | $19.5K | 0.001% | US |
| uniQure N.V. | QURE | — NL0010696654 | EC CORP | 23,202 NS | $379.4K | 0.015% | NL |
| Soleno Therapeutics, Inc. | — | 834203309 US8342033094 | EC CORP | 18,984 NS | $635.6K | 0.025% | US |
| Waystar Holding Corp. | WAY | 946784105 US9467841055 | EC CORP | 33,094 NS | $797.9K | 0.031% | US |
| Alignment Healthcare, Inc. | ALHC | 01625V104 US01625V1044 | EC CORP | 47,694 NS | $840.4K | 0.033% | US |
| Summit Therapeutics Inc. | SMMT | 86627T108 US86627T1088 | EC CORP | 46,947 NS | $890.1K | 0.035% | US |
| ADMA Biologics, Inc. | ADMA | 000899104 US0008991046 | EC CORP | 99,313 NS | $894.8K | 0.035% | US |
| Sotera Health LLC | SHC | 83601L102 US83601L1026 | EC CORP | 63,413 NS | $909.3K | 0.036% | US |
| Jackson National Asset Management, LLC JNL Government Money Market Fund - Class SL | — | 46628D395 — | STIV RF | 937,447.25 NS | $937.4K | 0.037% | US |
| Brightspring Health Services, Inc. | BTSG | 10950A106 US10950A1060 | EC CORP | 28,529 NS | $1.22M | 0.048% | US |
| Doximity, Inc. | DOCS | 26622P107 US26622P1075 | EC CORP | 56,646 NS | $1.32M | 0.052% | US |
| TransMedics Group, Inc. | TMDX | 89377M109 US89377M1099 | EC CORP | 13,303 NS | $1.32M | 0.052% | US |
| Viking Therapeutics, Inc. | VKTX | 92686J106 US92686J1060 | EC CORP | 45,085 NS | $1.47M | 0.057% | US |
| RadNet, Inc. | RDNT | 750491102 US7504911022 | EC CORP | 28,185 NS | $1.58M | 0.062% | US |
| Crinetics Pharmaceuticals, Inc. | CRNX | 22663K107 US22663K1079 | EC CORP | 43,376 NS | $1.58M | 0.062% | US |
| Bruker Corporation | BRKR | 116794108 US1167941087 | EC CORP | 43,634 NS | $1.58M | 0.062% | US |
| Irhythm Holdings, Inc. | IRTC | 450056106 US4500561067 | EC CORP | 13,394 NS | $1.58M | 0.062% | US |
| Tempus AI, Inc. | TEM | 88023B103 US88023B1035 | EC CORP | 36,508 NS | $1.65M | 0.065% | US |
| Corcept Therapeutics Incorporated | CORT | 218352102 US2183521028 | EC CORP | 41,239 NS | $1.66M | 0.065% | US |
| Merit Medical Systems, Inc. | MMSI | 589889104 US5898891040 | EC CORP | 25,476 NS | $1.76M | 0.069% | US |
| Hims & Hers Health, Inc. | HIMS | 433000106 US4330001060 | EC CORP | 88,192 NS | $1.83M | 0.072% | US |
| Arcellx Inc. | — | 03940C100 US03940C1009 | EC CORP | 16,175 NS | $1.86M | 0.073% | US |
| Option Care Health, Inc. | OPCH | 68404L201 US68404L2016 | EC CORP | 69,568.75 NS | $1.87M | 0.073% | US |
| CRISPR Therapeutics AG | CRSP | — CH0334081137 | EC CORP | 40,181 NS | $1.91M | 0.075% | CH |
| Kymera Therapeutics, Inc. | KYMR | 501575104 US5015751044 | EC CORP | 23,111 NS | $1.92M | 0.075% | US |
| Nuvalent, Inc. | — | 670703107 US6707031075 | EC CORP | 18,963 NS | $1.94M | 0.076% | US |
| Rhythm Pharmaceuticals, Inc. | RYTM | 76243J105 US76243J1051 | EC CORP | 22,633 NS | $1.97M | 0.077% | US |
| PTC Therapeutics, Inc. | PTCT | 69366J200 US69366J2006 | EC CORP | 29,958 NS | $2.04M | 0.080% | US |
| TG Therapeutics, Inc. | TGTX | 88322Q108 US88322Q1085 | EC CORP | 62,677 NS | $2.08M | 0.082% | US |
| Lantheus Holdings, Inc. | LNTH | 516544103 US5165441032 | EC CORP | 29,378 NS | $2.23M | 0.087% | US |
| Avantor, Inc. | AVTR | 05352A100 US05352A1007 | EC CORP | 292,728 NS | $2.29M | 0.090% | US |
| Davita Inc. | DVA | 23918K108 US23918K1088 | EC CORP | 15,164 NS | $2.33M | 0.091% | US |
| Bio-Rad Laboratories, Inc. | BIO | 090572207 US0905722072 | EC CORP | 8,409 NS | $2.34M | 0.092% | US |
| Protagonist Therapeutics, Inc. | PTGX | 74366E102 US74366E1029 | EC CORP | 22,383 NS | $2.36M | 0.092% | US |
| Alkermes Public Limited Company | ALKS | — IE00B56GVS15 | EC CORP | 66,757 NS | $2.36M | 0.093% | IE |
| Chemed Corporation | CHE | 16359R103 US16359R1032 | EC CORP | 6,276 NS | $2.37M | 0.093% | US |
| Teleflex Incorporated | TFX | 879369106 US8793691069 | EC CORP | 19,971 NS | $2.39M | 0.094% | US |
| Glaukos Corporation | GKOS | 377322102 US3773221029 | EC CORP | 22,489 NS | $2.42M | 0.095% | US |
| Repligen Corporation | RGEN | 759916109 US7599161095 | EC CORP | 22,943 NS | $2.70M | 0.106% | US |
| Axsome Therapeutics, Inc. | AXSM | 05464T104 US05464T1043 | EC CORP | 16,713 NS | $2.82M | 0.111% | US |
| Krystal Biotech, Inc. | KRYS | 501147102 US5011471027 | EC CORP | 10,949 NS | $2.83M | 0.111% | US |
| Molina Healthcare, Inc. | MOH | 60855R100 US60855R1005 | EC CORP | 21,785 NS | $2.90M | 0.114% | US |
| HealthEquity, Inc. | HQY | 42226A107 US42226A1079 | EC CORP | 36,364 NS | $3.04M | 0.119% | US |
| Praxis Precision Medicines, Inc. | PRAX | 74006W207 US74006W2070 | EC CORP | 9,547 NS | $3.08M | 0.121% | US |
| Vaxcyte, Inc. | PCVX | 92243G108 US92243G1085 | EC CORP | 54,695 NS | $3.18M | 0.125% | US |
| Arrowhead Pharmaceuticals Inc | ARWR | 04280A100 US04280A1007 | EC CORP | 51,258 NS | $3.21M | 0.126% | US |
| Cytokinetics, Incorporated | CYTK | 23282W605 US23282W6057 | EC CORP | 49,976 NS | $3.29M | 0.129% | US |
| Henry Schein, Inc. | HSIC | 806407102 US8064071025 | EC CORP | 45,209 NS | $3.33M | 0.131% | US |
| Charles River Laboratories International, Inc. | CRL | 159864107 US1598641074 | EC CORP | 19,421 NS | $3.35M | 0.131% | US |
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 98.9% of reported value reaches a classification.
Percentages are of the reported value of positions above ($2.55B), not of the fund’s net assets ($2.55B). The two differ by cash, derivatives filed with no market value, and rounding.